These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21876633)

  • 1. Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.
    Shu Y; Wang B; Wang J; Wang JM; Zou SQ
    World J Gastroenterol; 2011 Aug; 17(29):3407-19. PubMed ID: 21876633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors.
    Sriraksa R; Zeller C; Dai W; Siddiq A; Walley AJ; Limpaiboon T; Brown R
    Cancer Prev Res (Phila); 2013 Dec; 6(12):1348-55. PubMed ID: 24089088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.
    Yang B; House MG; Guo M; Herman JG; Clark DP
    Mod Pathol; 2005 Mar; 18(3):412-20. PubMed ID: 15467712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma.
    Uhm KO; Lee JO; Lee YM; Lee ES; Kim HS; Park SH
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):187-94. PubMed ID: 19655168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma.
    Uhm KO; Lee ES; Lee YM; Kim HS; Park YN; Park SH
    Oncol Res; 2008; 17(4):151-7. PubMed ID: 18773859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
    Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
    Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma.
    Liang J; Liu T; Liao J; Zhang L; Zhou M; Xu W; He Y; Cai G; Jin G; Song J; Li G; Liang H; Ding Z; Zhang B
    J Cell Physiol; 2021 Apr; 236(4):3143-3156. PubMed ID: 32996133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
    Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE
    Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
    Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
    Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma.
    Nanok C; Jearanaikoon P; Proungvitaya S; Limpaiboon T
    Mol Med Rep; 2018 Mar; 17(3):4145-4153. PubMed ID: 29359783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
    Iwaki J; Kikuchi K; Mizuguchi Y; Kawahigashi Y; Yoshida H; Uchida E; Takizawa T
    PLoS One; 2013; 8(7):e69496. PubMed ID: 23922722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma.
    Chen YJ; Tang QB; Zou SQ
    World J Gastroenterol; 2005 Mar; 11(9):1333-8. PubMed ID: 15761971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.
    Huang QX; Cui JY; Ma H; Jia XM; Huang FL; Jiang LX
    Cancer Gene Ther; 2016; 23(2-3):48-53. PubMed ID: 26679756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
    Wehbe H; Henson R; Meng F; Mize-Berge J; Patel T
    Cancer Res; 2006 Nov; 66(21):10517-24. PubMed ID: 17079474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
    Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
    Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.
    Chen YJ; Luo J; Yang GY; Yang K; Wen SQ; Zou SQ
    World J Gastroenterol; 2012 Aug; 18(29):3849-61. PubMed ID: 22876037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.